Uncategorized
The All India Institute of Medical Sciences (AIIMS) has reported first nerve brain damage due to COVID-19 , this patient is just 11 yr old girl.
” In adults such cases have been reported but in Paediatric this is the first case so far.” Says Dr.Sheffali Gulati, Chief , Child Neurology Division, AIIMS
According to the AIIMS draft report, the neurological problems related to COVID-19 are rare and only a few cases reported so far. The recent case is of a 11-year-old girl who lost her vision and a 12-year-old with ischemic stroke (secondary to focal cerebral arteriopathy) “Neurological manifestations associated with COVID 19 in children are rare and limited to few case reports/series. These case reports illustrate acute symptomatic seizures, new-onset status epilepticus (secondary to probable encephalitis) in an 11-year-old, ischemic stroke (secondary to focal cerebral arteriopathy) in a 12-year-old.”
“This girl had come to us with a loss of vision. We tested it as routine before admission into ward from casualty but significantly she is improving.” Says Dr.Sheffali Gulati, Chief , Child Neurology Division, AIIMS
The girl was undergoing treatment under Dr. Sheffali and now she has been discharged after giving immunotherapy her 50% of vision regained during treatment in AIIMS.
As we know that Covid-19 is likely to around for a long time. So, It’s important to take precautions “Children have to be taught all the things, it’s difficult but need to be done. Especially difficult for children who have special needs and may not be able to understand all this.” Says Dr.Shefali Gulati, Chief, Child Neurology Division, AIIMS
Less immunization is also one of the reason so its important for parents to get their children immunization timely.
“We have to have routine immunizations continued which have become less during this lockdown etc.” Dr. Sheffali Adds
By Dr Narendra Saini
SARS-CoV-2, Covid 19 Update
Cases : 40,648,527 deaths :1,122,992
US Cases 8,456,653 death 225222
India : Cases 7,594,736
death :115236
Brazil : cases 5,251,127 deaths : 154226 (worldometer)
Nitric oxide a possible treatment for COVID-19
Nitric oxide is a substance produced naturally in the body, playing many important roles in human health. It is an antimicrobial and anti-inflammatory molecule with key roles in pulmonary vascular function.NO can be administered as inhaled gas, in low concentrations, to boost the blood-oxygen saturation level.One key reason for the successful results was that inflammation in the patients’ lungs decreased.Published findings from the 2004 SARS-CoV infection suggest the potential role of inhaled nitric oxide as a supportive measure for treating infection in patients with pulmonary complications. Treatment with NO reversed pulmonary hypertension, improved severe hypoxia, and shortened the length of ventilatory support compared with matched control patients with SARS.The study published in the journal Redox Biology stated the compound beside antimicrobial property acts as a hormone and controls various organs, including the tension in the muscles of the blood vessels and the blood flow between and within organs.The dosage and timing of starting treatment probably play an important part in the outcome, and now need to be explored
face coverings (nose &mouth) should be part of new normal.
Smoking in any form at this time should be banned in public places as it may increase the spread of virus
Teamwork and feeling of openness is important for winning this Corona war
Dr Narendra Saini
Chairman Scientific
committee DMC
Chairman AMR committee IMA Hq
Past Sec Gen IMA
Director SAINI DIAGNOSTICS ICMR approved lab for RTPCR testing
Live coronavirus found on packaging of imported frozen fish, China health authority confirms
Live coronavirus found on packaging of imported frozen fish, China health authority confirms
living novel coronavirus has been isolated from the outer packaging of cold-chain food, the Chinese Centre for Disease Control and Prevention (CDC) informed.The finding was made during an investigation to trace the source of recent infections.Out of total,2.98 million samples tested across the country,22 samples from cold-chain food or food packaging tested positive for the virus.The CDC said it detected and isolated the living virus on the outer packaging of imported frozen cod in Qingdao.We should be careful and must disinfect the outer covering and wash our hand hands while handling package foods
face coverings (nose &mouth) should be part of new normal.
Smoking in any form at this time should be banned in public places as it may increase the spread of virus
Teamwork and feeling of openness is important for winning this Corona war
SARS-CoV-2,Covid 19,Update
Cases : 40,280,249 deaths :1,118,321
US Cases 8,387,799 death 224730
India : Cases 7,550,273
death :114642
Brazil : cases 5,235,344 deaths : 153904 (worldometer)
According to Indian Council of Medical Research ICMR total of 9 50,83,976 samples tested for COVID 19 up to 18th October out Of these, 8,59,786 samples were tested yesterday.
Glenmark has received approval for Sirolimus tablets, 0.5mg, 1mg, and 2mg
After the announcement of Pulmonary Fibrosis treatment in India Glenmark has announced today about receiving approval for Sirolimus tablets, 0.5mg, 1mg, and 2mg.In a regulatory filing, Glenmark said ” Glenmark Pharmaceuticals Inc., USA (Glenmark) has received
final approval by the United States Food & Drug Administration (U.S. FDA) for Sirolimus Tablets, 0.5 mg, 1 mg and 2 mg, the generic version of Rapamune®1 Tablets, 0.5 mg, 1 mg, and 2 mg, of PF Prism CV.”
Serum & Bharat Biotech can do intranasal vaccine trials in India after approval Says Dr. Harsh Vardhan
Bharat Biotech and Serum India may pursue clinical trials in India of intranasal vaccine on Covid-19 after receiving approval from the regulatory authority in the coming months. During Sunday Samvaad-16 Union Health Minister Dr. Harsh Vardhan said “There are no intranasal COVID-19 vaccines in India at the moment, Serum India and Bharat Biotech are expected to pursue clinical trials of such vaccines in India in the coming months on receipt of regulatory approval.
By Dr Narendra Saini
SARS-CoV-2,Covid 19,Update
Cases : 39,959,651 deaths : 1,114,636
US Cases 8,342,665 death 224282
India : Cases 7,494,551
death :114064
Brazil : cases 5,224,362 deaths : 153690, (worldometer)
Small Household Gatherings Driving COVID Increase,CDC
The increasing threat right now is acquisition of infection through small household gathering. Thanks giving and other holidays coming up,these gatherings could become a major concern.it’s really important to stress the vigilance of continued mitigation steps in the household setting.This virus can spread among families and among friends if you take your mask off and are primarily indoors.When in private, we need to take the same precautions that we take in public.This could mean providing a safe space for vulnerable family members to sit and interact at a distance and wearing masks inside the house. When eating, family members may sit farther apart to prevent the spread of the virus.We know that holidays become transmission events and so we have to be careful both in public and in private
face coverings (nose &mouth) should be part of new normal.
Smoking in any form at this time should be banned in public places as it may increase the spread of virus
Teamwork and feeling of openness is important for winning this Corona war
Dr Narendra Saini
Chairman Scientific
committee DMC
Chairman AMR committee IMA Hq
Past Sec Gen IMA
Director SAINI DIAGNOSTICS ICMR approved lab for RTPCR testing